On April 26, 2009, public health officials from the Centers for Disease Control (CDC) and the U.S. Secretary of Homeland Security held a press conference and declared a national public health emergency. The declaration came in response to identification of a new novel Influenza A (H1N1) “swine flu” virus (combination of swine, bird and human influenza viruses) that was making people sick and causing deaths in Mexico. By June 11, the World Health Organization (WHO) raised the global influenza pandemic alert to the highest Phase 6 level.U.S. Food and Drug Administration (FDA) has approved the use of one dose of vaccine against 2009 H1N1 influenza virus for persons 10 years of age & older. For children who are 6 months through 9 years of age, two doses of the vaccine are recommended. These two doses should be separated by 4 weeks.
According the report, Large-Scale Investments Pose Entry Barriers for Smaller Players is one of the primary growth factors for the market. Favorable government initiatives
is also expected to contribute significantly to the H1N1 (swine flu) Vaccination market. Overall, applications of H1N1 (swine flu) Vaccination, and the growing awareness of them, is what makes this segment of the industry important to its overall growth.
AMAs Analyst on the Global H1N1 (swine flu) Vaccination market identified that the demand is rising in many different parts of the world as "Opportunity for emerging economies
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global H1N1 (swine flu) Vaccination market according to Type, Application, and regions o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders insights and key drivers & trends of the market
Market Size Estimation In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the H1N1 (swine flu) Vaccination market and other related sub-markets covered in the study.
o Key & emerging players in the H1N1 (swine flu) Vaccination market have been observed through secondary research. o The industrys supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes. o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation The overall H1N1 (swine flu) Vaccination market size is calculated using market estimation process, the H1N1 (swine flu) Vaccination market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global H1N1 (swine flu) Vaccination market size has been validated using both top-down and bottom-up approaches.